Merck (NYSE:MRK) on Thursday announced plans to invest $895M to expand a manufacturing facility in Kansas, becoming the latest pharma major to boost capital expenditure in the U.S. amid the Trump administration’s tariff threats.

Merck Animal Health, a unit of Merck, said on Thursday it would invest $895 million to expand its manufacturing facility in De Soto, Kansas.The capital expansion includes an investment of $860 million in the site's existing manufacturing facility and a further $35 million in its research and development laboratories,

TOPEKA — Merck Animal Health will build an $895 million capital expansion project and add 200 jobs at its De Soto manufacturing facility, Gov. Laura Kelly and the company announced Thursday. Merck will invest $860 million in its existing facility and $35 million in its research and development laboratories, a press release said.